407 related articles for article (PubMed ID: 34333074)
1. In situ activation of therapeutics through bioorthogonal catalysis.
Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterial-based bioorthogonal nanozymes for biological applications.
Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
[TBL] [Abstract][Full Text] [Related]
3. All-natural gelatin-based bioorthogonal catalysts for efficient eradication of bacterial biofilms.
Nabawy A; Huang R; Luther DC; Zhang X; Li CH; Makabenta JM; Rotello VM
Chem Sci; 2022 Oct; 13(41):12071-12077. PubMed ID: 36349111
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
[TBL] [Abstract][Full Text] [Related]
5. Bioorthogonal nanozymes: an emerging strategy for disease therapy.
Zhang Z; Fan K
Nanoscale; 2022 Dec; 15(1):41-62. PubMed ID: 36512377
[TBL] [Abstract][Full Text] [Related]
6. Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.
Huang R; Li CH; Cao-Milán R; He LD; Makabenta JM; Zhang X; Yu E; Rotello VM
J Am Chem Soc; 2020 Jun; 142(24):10723-10729. PubMed ID: 32464057
[TBL] [Abstract][Full Text] [Related]
7. Progress in controllable bioorthogonal catalysis for prodrug activation.
Liu X; Huang T; Chen Z; Yang H
Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
[TBL] [Abstract][Full Text] [Related]
8. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.
Huang R; Hirschbiegel CM; Lehot V; Liu L; Cicek YA; Rotello VM
Adv Mater; 2024 Mar; 36(10):e2300943. PubMed ID: 37042795
[TBL] [Abstract][Full Text] [Related]
9. Bioorthogonal nanozymes for breast cancer imaging and therapy.
Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM
J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable Antibacterial Bioorthogonal Polymeric Nanocatalysts Prepared by Flash Nanoprecipitation.
Fedeli S; Huang R; Oz Y; Zhang X; Gupta A; Gopalakrishnan S; Makabenta JMV; Lamkin S; Sanyal A; Xu Y; Rotello VM
ACS Appl Mater Interfaces; 2023 Mar; 15(12):15260-15268. PubMed ID: 36920076
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
[TBL] [Abstract][Full Text] [Related]
12. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
[TBL] [Abstract][Full Text] [Related]
13. Designer Nanoreactors for Bioorthogonal Catalysis.
Kumar A; Lee IS
Acc Chem Res; 2024 Feb; 57(3):413-427. PubMed ID: 38243820
[TBL] [Abstract][Full Text] [Related]
14. A narrative review: progress in transition metal-mediated bioorthogonal catalysis for the treatment of solid tumors.
Wan X; Zhang Y; Nie Y; Zhang K; Jin Z; Zhang Z; Gan L; Liu X; He J
Transl Cancer Res; 2023 Aug; 12(8):2181-2196. PubMed ID: 37701121
[TBL] [Abstract][Full Text] [Related]
15. From mechanism to mouse: a tale of two bioorthogonal reactions.
Sletten EM; Bertozzi CR
Acc Chem Res; 2011 Sep; 44(9):666-76. PubMed ID: 21838330
[TBL] [Abstract][Full Text] [Related]
16. Protection and Isolation of Bioorthogonal Metal Catalysts by Using Monolayer-Coated Nanozymes.
Zhang X; Fedeli S; Gopalakrishnan S; Huang R; Gupta A; Luther DC; Rotello VM
Chembiochem; 2020 Oct; 21(19):2759-2763. PubMed ID: 32400081
[TBL] [Abstract][Full Text] [Related]
17. Transition metal catalysts for the bioorthogonal synthesis of bioactive agents.
van de L'Isle MON; Ortega-Liebana MC; Unciti-Broceta A
Curr Opin Chem Biol; 2021 Apr; 61():32-42. PubMed ID: 33147552
[TBL] [Abstract][Full Text] [Related]
18. Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells.
Wang F; Zhang Y; Du Z; Ren J; Qu X
Nat Commun; 2018 Mar; 9(1):1209. PubMed ID: 29572444
[TBL] [Abstract][Full Text] [Related]
19. Beyond the Second Coordination Sphere: Engineering Dirhodium Artificial Metalloenzymes To Enable Protein Control of Transition Metal Catalysis.
Lewis JC
Acc Chem Res; 2019 Mar; 52(3):576-584. PubMed ID: 30830755
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured Heterogeneous Catalysts for Bioorthogonal Reactions.
Sousa-Castillo A; Mariño-López A; Puértolas B; Correa-Duarte MA
Angew Chem Int Ed Engl; 2023 Mar; 62(10):e202215427. PubMed ID: 36479797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
